Comparison of dialysis and dispersion methods for in vitro release determination of drugs from multilamellar liposomes

Dissolution Technologies

Volumn 15, Issue 2, 2008, Pages 7-10

  Shazly, Gamal ^a   Nawroth, Thomas ^a   Langguth, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; DISPERSANT; LIPOSOME; METOPROLOL; PHOSPHATE BUFFERED SALINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPON 90H; PINDOLOL; PROPRANOLOL; UNCLASSIFIED DRUG;

ARTICLE; DIALYSIS; DISPERSION; DRUG FORMULATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; PH; PHOSPHOLIPID VESICLE; PHYSICAL CHEMISTRY;

EID: 77954763327     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT150208P7     Document Type: Article

References (7)

1. D́Souza, S. S.; DeLuca, P. P. Methods to Assess in Vitro Drug Release from Injectable Polymeric Particulate Systems. Pharm. Res. 2006, 23 (3), 460-474.
2. Burgess, D. J.; Hussain, A. S.; Ingallinera, T. S.; Chen, M. L. Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS PharmSci. 2002, 4 (2), E7.
3. Port, R. E.; Schuster, C.; Port, C. R.; Bachert, P. Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging. Cancer Chemother. Pharmacol. 2006, 58 (5), 607-617.
4. Philipus, J. P.; Frisken, B. J. The Pressure-Dependence of the Size of Extruded Vesicles. Biophys. J. 2003, 85, 996-1004.
5. Ahn, B. N.; Kim, S. K.; Shim, C. K. Proliposomes as an intranasal dosage form for the sustained delivery of propranolol. J. Controlled Release 1995, 34, 203-210.
6. Saarinen-Savolainen, P.; Järvinen, T.; Taipale, H.; Urtti, A. Method for evaluating drug release from liposomes in sink conditions. Int. J. Pharm. 1997, 159, 27-33.
7. Tashiro, Y.; Sami, M.; Shichibe, S.; Kato, Y.; Hayakawa, E.; Itoh, K. Effect of lipophilicity on in vivo iontophoretic delivery. II. b-Blockers. Biol. Pharm. Bull. 2001, 24 (6), 671-677.